Advanced and Proprietary Medical and Wellness Formulations
Complete Formulary of Medical and Wellness Products
The portfolio contains a complete set of formulations
These medical and wellness formulations are an advanced line of pharmaceutical-grade cannabis formulas containing varying ratios of cannabidiol (“CBD”) and tetrahydrocannabinol (“THC”). The portfolio contains a full formulary of preparations including oral, sublingual, topical, and transdermal deliveries that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data. The advanced formulary is marketed with consumer, patient and medical community education and training.
Avicanna’s medical and wellness portfolio also forms the foundation of the Company’s pharmaceutical pipeline with the contribution of the formulations that form the basis of the products as well as the data generated from sales and participation of the products in real world evidence studies.
Medical Cannabis by Shoppers Commercial Portal
Including oral, sublingual, topical, and transdermal deliveries that have controlled dosing, enhanced absorption and stability studies supported by pre-clinical data
Canada’s leading pharmacy retailer with more than 30,000+ registered cannabis patients
Collaborative education and training strategy with clinics in the medical community
Successful segmentation medical patients and aging population
sales are to 41+ years of age
Sunnybrook Hospital: first medical cannabis brand to be available for dispensing in major hospital pharmacy
UHN-RWET: University Health Network medical cannabis real world evidence study
Commercial across Canada, Colombia and Barbados
Commercial across 3 channels in Canada including Adult Use, Clinical and Medical in partnership with Medical Cannabis by Shoppers
Adult use channel. Establishing the wellness category in partnership with retailers across – ON, AB, NB, SK and NB